Abstract
Giggle incontinence (GI) is poorly described, defined, and understood. It is considered a bladder storage disorder in which laughter causes an uncontrollable episode of urinary incontinence that cannot be stopped until the bladder is completely emptied. It has been confused with stress urinary incontinence and overactive bladder. A thorough analysis of 26 articles on the subject of “giggle incontinence” and associated terms was performed, including all articles since the phrase first appeared. To date, 351 GI cases have been reported. It occurs mainly in women (69.5%) at 5 years of age, with a prevalence ranging from 8.4 to 16.2 years (average age of 12.4 years), and some cases have a family history of the disease (13–16.7%). This review discusses the historical background, current understanding, and challenges related to GI. It primarily affects females after the age of 5 years, causing complete bladder emptying during uncontrollable laughter. The exact cause is unknown, but hypotheses suggest involvement of the central nervous system. Diagnosis relies on clinical history, physical tests, and urine frequency evaluation. Management involves urotherapy techniques, biofeedback, and methylphenidate. Understanding GI will aid in developing more effective management techniques.
Impact
-
Highlights limited awareness among healthcare professionals about giggle incontinence as a distinct condition, emphasizing the need for standardized diagnostic criteria and assessment tools.
-
Addresses insufficient understanding of the underlying mechanisms and contributing factors, providing valuable insights for better diagnosis and treatment.
-
Emphasizes the importance of patient education and support, calling for improved resources and counseling.
-
Urges further research and evidence-based guidelines to enhance treatment strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data used in this study are available upon request to the corresponding author.
References
San, S. T., Barnes, E. H. & Caldwell, P. H. Y. Urinary incontinence during laughter in children: is it giggle incontinence? J. Paediatr. Child Health 57, 1971–1975 (2021).
Chang, J. H. et al. Clinical and urodynamic effect of methylphenidate for the treatment of giggle incontinence (enuresis risoria). Neurourol. Urodyn. 30, 1338–1342 (2011).
Nieuwhof-Leppink, A. J. et al. Daytime urinary incontinence in children and adolescents. Lancet Child Adolesc. Health 3, 492–501 (2019).
Chandra, M., Saharia, R., Shi, Q. & Hill, V. Giggle incontinence in children: a manifestation of detrusor instability. J. Urol. 168, 2184–2187 (2002).
Millard, D. W. Giggle micturition—a misnomer? Br. Med. J. 1, 1674 (1965).
Austin, P. F. et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol. Urodyn. 35, 471–481 (2016).
Mackeith, R. C. Micturition induced by giggling? Br. Med. J. 34, 358 (1959).
Mackeith, R. C. Micturition induced by giggling. Guys Hosp. Rep. 113, 250–260 (1964).
Millard, D. W. A conditioning treatment for ‘giggle micturition’. Behav. Res. Ther. 4, 229–231 (1966).
de Jonge, G. A. Enuresis risoria (giggle micturition) (Dutch). Ned. Tijdschr. Geneeskd. 119, 1335–1338 (1975).
Logan, B. L., Foster-Johnson, L. & Zotos, E. Urinary incontinence among adolescent female athletes. J. Pediatr. Urol. 14, 241.e1–241.e9 (2018).
Shrestha, N., Sahukhala, S., Diva, K. C., Sandalcidi, D. & Adhikari, S. P. Prevalence of urinary incontinence in school going children: a cross-sectional study. J. Nepal Health Res. Counc. 18, 676–680 (2021).
Linde, J. M., Nijman, R. J. M., Trzpis, M. & Broens, P. M. A. Prevalence of urinary incontinence and other lower urinary tract symptoms in children in the Netherlands. J. Pediatr. Urol. 15, 164.e1–164.e7 (2019).
Franco, I. Overactive bladder in children. Nat. Rev. Urol. 13, 520–532 (2016).
Svendsen, A. M. et al. The effect of methylphenidate for giggle incontinence in children. Neurourol. Urodyn. 42, 1470–1475 (2023).
Wefer, B. et al. [Botulinum toxin A injection for treatment-refractory giggle incontinence]. Urologe A 46, 773–775 (2007).
Telli, O. et al. Can the success of structured therapy for giggle incontinence be predicted? Int. Braz. J. Urol. 42, 334–338 (2016).
Provine, R. R. Laughing, tickling, and the evolution of speech and self. Curr. Dir. Psychol. Sci. 13, 215–218 (2016).
Pearce, J. M. S. Some neurological aspects of laughter. Eur. Neurol. 52, 169–171 (2004).
Glahn, B. E. Giggle incontinence (enuresis risoria). A study and an aetiological hypothesis. Br. J. Urol. 51, 363–366 (1979).
Mohan Kunnath, S. et al. Urodynamic characterization of giggle incontinence in children. Neurourol. Urodyn. 40, 1600–1608 (2021).
Feldman, A. S. & Bauer, S. B. Diagnosis and management of dysfunctional voiding. Curr. Opin. Pediatr. 18, 139–147 (2006).
Meletti, S. et al. The brain correlates of laugh and cataplexy in childhood narcolepsy. J. Neurosci. 35, 11583–11594 (2015).
Miyagawa, T. & Tokunaga, K. Genetics of narcolepsy. Hum. Genome Var. 6, 4 (2019).
Broumand, Z. et al. Correlation between attention deficit hyperactivity disorder and giggle incontinence. Prensa Med. Argent. 105, 3 (2019).
Akaltun, İ., Kara, T. & Ayaydın, H. A case of an 11-year-old girl diagnosed with OCD developing giggle incontinence following addition of aripiprazole to treatment. Psychiatr. Clin. Psychopharmacol. 28, 343–345 (2017).
Eickmeyer, S. M. Anatomy and physiology of the pelvic floor. Phys. Med. Rehabil. Clin. N. Am. 28, 455–460 (2017).
Frank, C., Kobesova, A. & Kolar, P. Dynamic neuromuscular stabilization & sports rehabilitation. Int. J. Sports Phys. Ther. 8, 62 (2013).
Whitney, K. E. et al. Low energy availability and impact sport participation as risk factors for urinary incontinence in female athletes. J. Pediatr. Urol. 17, 290.e1–290.e7 (2021).
Chase, J. & Schrale, L. Childhood incontinence and pelvic floor muscle function: can we learn from adult research? J. Pediatr. Urol. 13, 94–101 (2017).
Chess-Williams, R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton. Autacoid Pharmacol. 22, 133–145 (2002).
Burgard, E. C., Fraser, M. O. & Thor, K. B. Serotonergic modulation of bladder afferent pathways. Urology 62, 10–15 (2003).
Elzinga-Plomp, A. et al. Treatment of enuresis risoria in children by self-administered electric and imaginary shock. Br. J. Urol. 76, 775–778 (1995).
Franco, I., Arlen, A. M., Collett-Gardere, T. & Zelkovic, P. F. Imipramine for refractory daytime incontinence in the pediatric population. J. Pediatr. Urol. 14, 58.e1–58.e5 (2018).
Sher, P. K. & Reinberg, Y. Successful treatment of giggle incontinence with methylphenidate. J. Urol. 156, 656–658 (1996).
Berry, A. K., Zderic, S. & Carr, M. Methylphenidate for giggle incontinence. J. Urol. 182, 2028–2032 (2009).
Ravanshad, Y. et al. Clinical effects of methylphenidate compared to oxybutynin on management of giggle incontinence. J. Pediatr. Nephrol. 7, 1–3 (2019).
Fernandes, L., Martin, D. & Hum, S. A case of the giggles: diagnosis and management of giggle incontinence. Can. Fam. Physician 64, 445–447 (2018).
Deng, C., Chen, Y. & Dai, R. Urotherapy for giggle incontinence: a case report. Asian J. Surg. 45, 1986–1987 (2022).
Brocklebank, J. T. & Meadow, S. R. Cure og giggle micturition. Arch. Dis. Child. 56, 232–234 (1981).
Schäfer, S. K. et al. Standard urotherapy as first-line intervention for daytime incontinence: a meta-analysis. Eur. Child Adolesc. Psychiatry 27, 949–964 (2018).
Nieuwhof-Leppink, A., Larsson, J., Holmdahl, G. & Goyal, A. in Urotherapy Book A Case-Based Approach 57–70 (ESPU, ESPU-N, ICCS, 2022).
Richardson, I. & Palmer, L. S. Successful treatment for giggle incontinence with biofeedback. J. Urol. 182, 2062–2066 (2009).
Palmer, L. S. Biofeedback in the management of urinary continence in children. Curr. Urol. Rep. 11, 122–127 (2010).
Romikh, V. & Borisenko, L. C93: biofeedback with pelvic floor muscles electrostimulation in treatment of giggle urinary incontinence in young women. Eur. Urol. Suppl. 13, e1280 (2014).
Hacıislamoğlu, A. et al. Evaluation of the efficacies of methylphenidate and biofeedback treatments in giggle incontinence: one-year follow-up study. J. Pediatr. Urol. 17, 646.e1–646.e5 (2021).
Gottlieb, S. Methylphenidate works by increasing dopamine levels. Br. Med. J. 322, 259 (2001).
Shellenberg, T. P., Stoops, W. W., Lile, J. A. & Rush, C. R. An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. Expert Rev. Clin. Pharmacol. 13, 825–833 (2020).
Abdelmonem, I. I. et al. Giggle incontinence: a rare condition with a successful management. Urol. Case Rep. 42, 102033 (2022).
Arena, M. G. et al. ‘Enuresis resoria’: evaluation and management. Funct. Neurol. 2, 579–582 (1987).
Funding
This study did not receive funding from any institution or corporate entity. The authors declare that there was no involvement of any external funding source in the study design, data collection, analysis and interpretation, writing of the manuscript, or the decision to submit the manuscript for publication. All costs associated with the study were covered by the authors’ own resources.
Author information
Authors and Affiliations
Contributions
Patient data for GI cases were collected by Adrián A. González-Maldonado (AG) and Manuel García-Mérida (MG). Both reviewers contributed to the research design, implementation, and analysis. AG also contributed to result analysis and manuscript writing. MG conceived and supervised the project. Cases with additional urinary symptoms were excluded.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and informed consent
As this study is based on previously published research in the literature, ethical approval was not required. Obtaining informed consent was not necessary as this work constitutes a review of previously published studies.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
González-Maldonado, A.A., García-Mérida, M. Giggle incontinence: a scoping review. Pediatr Res 95, 1720–1725 (2024). https://doi.org/10.1038/s41390-024-03065-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-024-03065-y